The increasing number of positive SARS-CoV2 cases requires greater attention for a correct diagnosis and distinction from other viruses in circulation
In Brazil, data from Fiocruz indicate a increase in the national curve of positive cases for Covid-19 and other respiratory diseases. The correct identification of Covid-19 cases and their distinction from other viruses is fundamental for adequate clinical management and public policy guidance. The exam routines play a leading role in this scenario, informing the data from the issuance of their reports.
The increase in demand for these tests requires greater attention in the laboratory network, so that there is adequate identification and to know which viruses are most associated with the change in trend.
For the reliability of the reports, Controllab offers a wide portfolio of Quality Control (QC). Among the solutions, the QC includes external and internal controls and reference material.
These solutions avoid errors in the analytical phase and costs in repetitions. The preventive actions provided by quality tools are more efficient than corrective actions, as they avoid waste of inputs, optimize human labor and make analyzes more productive and reliable.
Check out the Covid-19 and other respiratory diseases programs that Controllab offers:
|
Routines |
Analysis |
|
TLR / Point of Care (POC) |
SARS-CoV2 molecular, serological and antigen |
|
Respiratory Syncytial Virus (RSV) molecular and serological |
|
|
Influenza A and B molecular and sorológico |
|
|
Molecular Biology |
|
|
Automation |
SARS-CoV2 serological and antigen |
